scholarly journals Effect of Renal Impairment on the Pharmacokinetics and Safety of Dorzagliatin, a Novel Dual‐acting Glucokinase Activator

2021 ◽  
Author(s):  
Jia Miao ◽  
Ping Fu ◽  
Shuang Ren ◽  
Chao Hu ◽  
Ying Wang ◽  
...  
Keyword(s):  
Renal Impairment ◽  
Glucokinase Activator

Prevalence and predictors of renal impairment after orthotopic liver transplantation

2013 ◽  
Vol 51 (01) ◽  
Author(s):  
MF Sprinzl ◽  
H Tönissen ◽  
A Weinmann ◽  
N Lohse ◽  
S Koch ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Renal Impairment ◽  
Orthotopic Liver Transplantation

Long-Term Safety of Tiotropium/Olodaterol Respimat in Patients with Moderate-to-Very Severe COPD and Renal Impairment in the TONADO Studies

Pneumologie ◽  
2018 ◽  
Vol 72 (S 01) ◽  
pp. S83-S83
Author(s):  
S Stieglitz ◽  
C LaForce ◽  
E Derom ◽  
U Bothner ◽  
L Loaiza ◽  
...  
Keyword(s):  
Renal Impairment ◽  
Severe Copd

Safety and Efficacy of Sitagliptin (SITA) Compared with Dapagliflozin (DAPA) in Subjects with T2D, Mild Renal Impairment, and Inadequate Glycemic Control on Metformin (MET) ± a Sulfonylurea (SU)

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1142-P
Author(s):  
RUSSELL S. SCOTT ◽  
JERRY D. MORGAN ◽  
ZACHARY ZIMMER ◽  
RAYMOND L.H. LAM ◽  
EDWARD A. O'NEILL ◽  
...  
Keyword(s):  
Glycemic Control ◽  
Renal Impairment ◽  
Mild Renal Impairment ◽  
Safety And Efficacy ◽  
Inadequate Glycemic Control

1004-P: Oral Semaglutide vs. Placebo in Patients with Type 2 Diabetes and Moderate Renal Impairment: PIONEER 5

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1004-P ◽  
Author(s):  
OFRI MOSENZON ◽  
SIGNE ROSENLUND ◽  
JAN W. ERIKSSON ◽  
SIMON R. HELLER ◽  
RICHARD E. PRATLEY ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Renal Impairment ◽  
Moderate Renal Impairment
Sign in / Sign up

Export Citation Format

Share Document